To view this email as a web page, click here.
 
DIABETES DRUGS
 
Blockbuster diabetes drug earns heart indication
A top-selling diabetes drug has gained a cardiovascular indication from FDA.
Read more
 
Will new biosimilars hurt blockbuster autoimmune drug?
New biosimilars approved in the US and Europe are expected to cut into the profitability of the blockbuster drug adalimumab (Humira) for Crohn’s disease and other autoimmune conditions.
Read more
 
DEA wants to slash opioid production
The Drug Enforcement Administration (DEA) wants to slash the production of opioid painkillers by 20% in 2018.
Read more
 
SURVEY
 
State of the Industry Survey 2017
Take three minutes to answer our State of the Industry Survey. As a thank-you to survey-takers, when the survey closes, we will hold a drawing to give away not one, but two $200 Visa gift cards.
Take survey
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.